Auto Tissue Berlin
As part of its recertification process due at the end of 2022, Auto Tissue Berlin, a manufacturer of cell-free biological implants, planned a PMCF study to generate further data on the clinical safety of its product. Previously, data capture had been conducted using Excel spreadsheets. This, however, required relatively frequent queries and made it difficult to strike a balance between clarity and complexity. Climedo Health's proven, validated and certified solution appealed to Auto Tissue Berlin given its attractive web-based user interface, scope of services and pricing model.
Prof. Dr. Christoph Schmitz
Chief Medical Officer, Auto Tissue Berlin
Christiane Weis, M.Sc.
Clinical Department, GELITA MEDICAL GmbH
Dr. Jens Milde
Managing Director, Pharmalog
Dr. med. dent. Wolfgang Maas
Oral Surgeon, Implantology Practice
Dr. med. Lena Oevermann
Med. specialist for paediatric haematology and oncology, Charité Berlin